Dr. Kevin Kavanagh from Health Watch USAsm
discusses the impending BA.4/BA.5 surge with increasing cases and
hospitalizations. So far, ICU admissions and deaths have not risen
significantly. With infections and hospitalizations comes the risks of
Long COVID. New research has found that over 60% of patients with Long
COVID have viral antigens in the blood. This may well be a sign of an
indolent subclinical infection of the virus.
Data from South Africa has shown a lower rate of hospitalizations with
the BA.4 and BA.5 variants. But unlike the United States they had a
large surge of the Beta Variant which offers protection against the BA.4
and BA.5 variants. The United States had a large wave with the Omicron
Variant which offers much less protection. Pre-Omicron, those infected
by the Delta Variant will have better protection providing their
immunity has not waned.
New variants are appearing almost once a month, far too quickly for a
specific vaccine. There is also another concerning variant in India the
BA2.75, which may be even more infectious. With the Seasonal Flu, we
have a new variant about once a year which allows for vaccine
modification. However, COVID vaccines do produce a wide range of
antibodies and will offer at least some protection against severe
disease. There are two bivalent vaccines which are being tested which
may offer even broader protection.
Vaccines are the safest way to augment your immunity, whether you have
had a previous vaccination or infection become boosted. Thus, we need to
take this virus seriously. We need to mask up, avoid indoor settings and
stay up to date on vaccinations and boosters. Jack Pattie Show with
Kruser (Dave Krusenkla). July 11, 2022.
In addition, please go to
https://healthconference.org and register for
our Sept. 14th webinar. There is a large list of world renowned speakers
and the event is free.
|